Searched for
HIV PREVENTION SUPPLIES
The impact of Trump's foreign aid cuts, one year onHumanitarian efforts to fight diseases such as HIV, malaria and tuberculosis in some of the world's poorest nations have been massively dis...- Aurobindo to produce, supply long acting HIV treatment drugAurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...
- Trump admin set to destroy vital HIV meds and contraceptives worth $12 million following closure of USAIDThe Trump government may destroy $12 million worth of HIV and birth control medicines bought to help poor countries. These medicines are st...
- Trump’s foreign aid freeze may put millions of children at HIV risk, warns Lancet reportA Lancet report warns that suspending or limiting funding to PEPFAR could lead to dire consequences in the African region. By 2030, one mil...
- Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug LenacapavirEmcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for HIV prevention a...
- New HIV cases down by 44% since 2010: Anupriya PatelNew annual HIV infections in India have decreased by 44 per cent since 2010, surpassing the global reduction rate of 39 per cent. Union Min...
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...
- A child or young person newly infected with HIV every 100 seconds last year: UNICEFWarning that children are being left behind in the fight against HIV, it said that prevention efforts and treatment for children remain som...
- A 'Lancet' study says Covid-19 pandemic may lead to surge in HIV, malaria deaths; timely treatment can save livesCore services for HIV, TB, and malaria could largely mitigate the broader health impact of the pandemic.
- Bill Gates invests $140 million in HIV cureThe Bill and Melinda Gates Foundation is providing funding for a groundbreaking new technology which could revolutionise HIV prevention.
- Having a debate will be a good starting point for HIV billHIV & AIDS (Prevention and Control) Bill, 2014 is also one of the few bills drafted with inputs from all stakeholders, particularly from th...
- India calls for flexibilities in IPR to combat AIDSJP Nadda said India will need to "front load" its investments substantially to almost double the number of people on ARV treatment in less ...
- HIV fears rise as six states face severe shortage of condomsThe matter was recently raised with the Union health ministry, following which the health secretary met senior officials from the NACO.
- New HIV cases down by 57%, India now aims for zero infectionThe number of new HIV infections in India has come down by 57 per cent and related deaths by 25 percent in the last decade.
- NHRC raps Health Ministry for delaying report on HIV drugsThe NHRC, vide a reminder on October 28 has given four weeks' time to the Ministry, through its Secretary, to submit the report, the statem...
- NHRC sends notice to Health Ministry over dearth of HIV drugs"The contents of the press report, if true, raise a serious issue of violation of human rights of HIV patients," observed the Commission.
- Stock-out hits HIV treatment across IndiaTreatment for HIV patients across India has taken a hit due to severe stock-outs reported at government-owned centres.
- Ranbaxy arm bags Rs 605 cr anti-HIV drug order in South AfricaThe 913.5 million rand order bagged by Sonke is a part of a 4.28 billion rand national anti-retroviral tender floated by the South African ...
- Delhi NGO opposes patent for Roche's HIV drugHIV patient group-Delhi Network of Positive People (DNP+)-has filed a post-grant opposition against Swiss major Roche’s patent for its HIV ...
- India Inc pulling out all stops to curb AIDSThe battle against HIV/AIDS, in its new avataar, has moved to the next level.
Load More
